Vetoryl Capsules (Trilostane) 5mg, Treatment for Cushing's Disease in Dogs

Vetoryl is a prescription medication prescribed to aid in your dog's treatment of hyperadrenocorticism, also known as Cushing's Disease. This medication treats both pituitary-dependent and adrenal-dependent cases, and controls the excess production of cortisol caused by the disease. Do not give this medication to pregnant dogs, or dogs with kidney or liver disease. All dogs should undergo a thorough history and physical examination before initiation of therapy with VETORYL Capsules. Other conditions, such as primary hepatic and/or renal disease should be considered when the patient is exhibiting signs of illness in addition to signs of hyperadrenocorticism.

• VETORYL Capsules are the only FDA approved pharmaceutical for the treatment of Pituitary-Dependent Hyperadrenocorticism (PDH) and Adrenal-Dependent Hyperadrenocorticism (ADH) in dogs. 
• VETORYL Capsules contain trilostane, which selectively, and reversibly, inhibits the enzyme 3ß-hydroxysteroid dehydrogenase, which is involved in the synthesis of several steroids including cortisol and aldosterone. 
• At recommended dose rates, VETORYL Capsules tend to have a more selective effect on glucocorticoid productioniii, however the potential inhibition of aldosterone must always be borne in mind by the attending clinician. 
• VETORYL Capsules reduce circulating cortisol levels, leading to improvement in many of the clinical signs of HAC. 
• VETORYL Capsules provide flexible and accurate dosing with five strengths (5 mg, 10 mg, 30 mg, 60 mg and 120 mg capsules), allowing you to restore the dog’s vitality by reducing the clinical signs associated with HAC. 
• Available in blister packs of 30 capsules for ease of dispensing.